Stock Analysis
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)HLN
Sector: Healthcare
AnalystsStrong Buy26 analystsPrice is 56% of the way from the year's low to its high.
PMP Verdict
Insufficient financial data
No financial statements on file for this ticker — fundamental scores are not computed.
Bull Case
- ✓Interest coverage 8.3× — debt well covered
What's happening with HLN
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is one of the largest consumer health companies in the world. Show more
Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Employees: 24,524 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
Valuation
50CP/E (TTM)—
Price / TTM EPS (own statements)
P/FCF14.3xA
Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield7.0%A
Grade A: ValueInverse of Finnhub P/FCF (own TTM FCF unavailable)
P/S (TTM)2.86xB
Grade B: FairPrice / TTM Revenue (own statements)
EV/EBITDA15.0xB
Grade B: FairEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales3.5xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E15.3xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio1.87xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio1.98B
Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield1.99%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio39.0%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
40D+ROIC—
NOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE9.9%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA5.0%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin14.6%A
Grade A: HighNet Income / Revenue
Operating Margin—
TTM EBIT / TTM Revenue
Gross Margin65.5%A
Grade A: PremiumGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
0ERevenue CAGR—
Compound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth—
Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income—
Stock-based comp/Net income. >30% = dilution risk
SBC / Revenue—
TTM stock-based comp / TTM Revenue
Financial Health
18EAltman Z-Score—
Bankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.69xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.52xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage8.3xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.50xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Quality
0EPiotroski F-Score—
Financial strength 0–9. >7 Strong
Beneish M-Score—
Earnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability—
EBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.34xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
0EROIC >12% Years—
Share of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)—
Median annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years—
Share of completed fiscal years with positive free cash flow
Net Margin Floor—
Weakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)—
TTM net income per share (Finnhub fallback)
Cash / Share$0.10
Cash & short-term investments per share (Finnhub)
Book Value / Share$1.89
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.—
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity—
Shareholders' equity (book value)
Asset / Liability—
Total Assets / Total Liabilities
Market
Market Cap$44.33B
Current Market Capitalization
Beta0.70B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Ratio snapshot Oct 17, 2026
See how HLN ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all HLN moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 7 | Pre-market | 9.13 | +2.93% | 2.47 |
Frequently Asked Questions about HLN
What is the current Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) stock price?
HLN is trading at $10.13 at the last market close, up 1.91% on the session. PreMarketPrice tracks HLN pre-market, intraday and after-hours prices.
Is HLN stock a buy right now?
PreMarketPrice's quantitative model rates Haleon plc American Depositary Shares (Each representing two Ordinary Shares)'s financial health at 18/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is HLN stock overvalued?
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at a trailing P/E of n/a and our valuation score rates it 50/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Haleon plc American Depositary Shares (Each representing two Ordinary Shares) report earnings?
No confirmed earnings date is currently scheduled for HLN. The Earnings section lists recent reports and updates as dates are announced.
What sector does Haleon plc American Depositary Shares (Each representing two Ordinary Shares) operate in?
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) operates in the Healthcare sector. The Related Stocks section lists sector peers for comparison.
What does Haleon plc American Depositary Shares (Each representing two Ordinary Shares) do?
Haleon is one of the largest consumer health companies in the world.
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Stock
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) is a US-listed stock operating in the Healthcare sector. As of the latest update, Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is trading at $10.13, up 1.91% on the day with a market capitalization of $44.3 billion. The financial health score for HLN is 18/100, which indicates poor financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for HLN stock.
HLN Stock Analysis & Key Metrics
On PreMarketPrice, you can track Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) across multiple dimensions:
- Pre-market price & movement: Real-time HLN stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for HLN with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Haleon plc American Depositary Shares (Each representing two Ordinary Shares) across multiple reporting periods.
- Financial health score: A composite score of 18/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for HLN.
- Sector peers: Compare HLN against 2 other healthcare stocks on key financial metrics.
Is HLN a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) as an investment. The financial health score of 18/100 suggests poor financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.